0001123292-17-000213.txt : 20170120
0001123292-17-000213.hdr.sgml : 20170120
20170120154627
ACCESSION NUMBER: 0001123292-17-000213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170118
FILED AS OF DATE: 20170120
DATE AS OF CHANGE: 20170120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENWOOD GERALDINE
CENTRAL INDEX KEY: 0001236451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 17538521
MAIL ADDRESS:
STREET 1: 88 SIDNEY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-01-18
0001588972
Recro Pharma, Inc.
REPH
0001236451
HENWOOD GERALDINE
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19335
1
1
0
0
Chief Executive Officer
Employee Stock Option (right to buy)
7.33
2017-01-18
4
A
0
144700
0
A
2027-01-18
Common Stock
144700
144700
D
Restricted Stock Units
2017-01-18
4
A
0
20000
0
A
Common Stock
20000
20000
D
The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units vest in four equal annual installments beginning January 18, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
/s/ Donna Nichols, as Attorney-in-Fact
2017-01-20